Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
Despite challenging reimbursement environments, evolving regulatory requirements, limited clinical evidence for newer products, and lingering negative publicity surrounding key products, the global market for BGS will undergo moderate growth due to a good balance of rapidly expanding emerging markets in the Asia Pacific and Latin America regions and developed economies in the US and Europe.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for BGS in the US, Europe, Asia Pacific, and Latin America across a 10-year period.
BGS products face varying levels of regulatory restrictions, significantly impacting product approvals and adoption.
How will companies use the regulatory landscape to their advantage in the US market?
How have and how will companies continue to ensure a successful product launch following approval?
Reimbursement for BGS products is facing greater scrutiny in Latin America.
Which countries have limited or a complete lack of reimbursement for these products?
What strategies can companies use to promote their products when reimbursement is lacking?
In the Asia Pacific and Latin American BGS markets, domestic manufacturers have gained significant market share.
How are domestic manufacturers' product offerings evolving in comparison to products offered by MNCs?
In which countries do domestic companies hold particularly high market shares, and why?
Already a Client? Log in to access this report.
Robert is an analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in aesthetic injectables, therapeutic botulinum toxin, cosmetic threads, breast reconstruction, and bone graft substitutes. Prior to joining DRG, Robert worked as a clinical research assistant in hematology. Robert holds an Honors Bachelor's degree in Immunology from McGill University.